Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 10, 2004, Pages 1120-1123

  Tamm, Michael ^a   Aboyoun, Christina L ^a   Chhajed, Prashant N ^a,b   Rainer, Stephen ^a   Malouf, Monique A ^a   Glanville, Allan R ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Bronchiolitis obliterans syndrome; Cytomegalovirus; Lung transplant

Indexed keywords

GANCICLOVIR;

ARTICLE; BRONCHIOLITIS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DONOR; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SERODIAGNOSIS; SURVIVAL; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIVIRAL AGENTS; BRONCHIOLITIS OBLITERANS; CHILD; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INCIDENCE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; POSTOPERATIVE COMPLICATIONS; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 8444246787     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200310-1405OC     Document Type: Article

References (27)

1. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Mohacsi PJ, Keck BM, Hertz MI. The registry of the international society for heart and lung transplantation: twentieth official adult lung and heart-lung transplant report-2003. J Heart Lung Transplant 2003;22:625-635.
2. Chamberlain D, Maurer J, Chaparro C, Idolor L. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant 1994;13:963-971.
3. Hopkins PM, Aboyoun CL, Chhajed PN, Malouf MA, Plit ML, Rainer SP, Glanville AR. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant 2002; 21:1062-1067.
4. Chhajed PN, Tamm M, Glanville AR. Role of flexible bronchoscopy in lung transplantation. Semin Respir Crit Care Med 2004;25:413-423.
5. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
6. Tikkanen JM, Kallio EA, Bruggeman CA, Koskinen PK, Lemstrom KB. Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by antiviral prophylaxis or immunosuppression in rat tracheal allografts. Am J Respir Crit Care Med 2001;164:672-679.
7. Theise ND, Haber MM, Grimes MM. Detection of cytomegalovirus in lung allografts: comparison of histologic and immunohistochemical findings. Am J Clin Pathol 1991;96:762-766.
8. Duncan SR, Paradis IL, Yousem SA, Similo SL, Grgurich WF, Williams PA, Dauber JH, Griffith BP. Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis 1992;146: 1419-1425.
9. Aboyoun CL, Tamm M, Chhajed PN, Hopkins P, Malouf MA, Rainer S, Glanville AR. Diagnostic value of follow-up transbronchial lung biopsy after lung rejection. Am J Respir Crit Care Med 2001;164:460-463.
10. Yousem SA, Berry GJ, Cagle PT, Chamberlain D, Husain AN, Hruban RH, Marchevsky A, Ohori NP, Ritter J, Stewart S, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant 1996;15:1-15.
11. Statement of the American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis 1987;136:1285-1298.
12. Ettinger NA, Bailey TC, Trulock EP, Storch GA, Anderson D, Raab S, Spitznagel EL, Dresler C, Cooper JD. Washington University Lung Transplant Group. Cytomegalovirus infection and pneumonitis: impact after isolated lung transplantation. Am Rev Respir Dis 1993;147: 1017-1023.
13. Duncan AJ, Dummer JS, Paradis IL, Dauber JH, Yousem SA, Zenati MA, Kormos RL, Griffith BP. Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant 1991;10:638-646.
14. Maurer JR, Tullis DE, Scavuzzo M, Patterson GA. Cytomegalovirus infection in isolated lung transplantations. J Heart Lung Transplant 1991;10:647-649.
15. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo TG, Yousem SA, Close JM, Zeevi A, Duquesnoy RJ, et al. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg 1995;110:4-14.
16. Keller CA, Cagle PT, Brown RW, Noon G, Frost AE. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation. Chest 1995;107:973-980.
17. Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Bolman RM III. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997;114:195-202.
18. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 1998;17:1255-1263.
19. Smith MA, Sundaresan S, Mohanakumar T, Trulock EP, Lynch JP, Phelan DL, Cooper JD, Patterson GA. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 1998;116:812-820.
20. Keenan RJ, Lega ME, Dummer JS, Paradis IL, Dauber JH, Rabinowich H, Yousem SA, Hardesty RL, Griffith BP, Duquesnoy RJ, et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991;51:433-438.
21. Sharples LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wall-work J. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation-early risk factors. Transplantation 1996; 61:560-566.
22. Husain AN, Siddiqui MT, Holmes EW, Chandrasekhar AJ, McCabe M, Radvany R, Garrity ER. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999;159:829-833.
23. Girgis RE, Tu I, Berry GJ, Reichenspurner H, Valentine VG, Conte JV, Ting A, Johnstone I, Miller J, Robbins RC, et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 1996;15:1200-1208.
24. Khalifah AP, Hachem RR, Chakinala MM, Schechtman KB, Patterson GA, Schuster DP, Mohanakumar T, Trulock EP, Walter MJ. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004;170:181-187.
25. Luckraz H, Sharples L, McNeil K, Wreghitt T, Wallwork J. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation. J Heart Lung Transplant 2003;22:287-291.
26. Dickenmann MJ, Cathomas G, Steiger J, Mihatsch MJ, Thiel G, Tamm M. Cytomegalovirus infection and graft rejection in renal transplantation. Transplantation 2001;71:764-767.
27. Dickenmann MJ, Kabulbayev K, Steiger J, Cathomas G, Reusser P, Tamm M. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejection. Clin Microbiol Infect 2004;10:337-339.